| Entry |
|
|---|
| Name |
Sulfamerazine (INN) |
|---|
| Formula |
C11H12N4O2S
|
|---|
| Exact mass |
264.0681
|
|---|
| Mol weight |
264.31
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Antibacterial
DG01787 Sulfonamide antibacterial
DG01786 Long-acting sulfonamide
|
|---|
| Remark |
|
|---|
| Efficacy |
Antibacterial, Folic acid biosynthesis inhibitor |
|---|
| Comment |
Sulfonamide
|
|---|
| Target |
dihydropteroate synthase [KO: K00796] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07016 | Sulfonamide derivatives - sulfa drugs |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE
D06B CHEMOTHERAPEUTICS FOR TOPICAL USE
D06BA Sulfonamides
D06BA06 Sulfamerazine
D02435 Sulfamerazine (INN)
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01E SULFONAMIDES AND TRIMETHOPRIM
J01ED Long-acting sulfonamides
J01ED07 Sulfamerazine
D02435 Sulfamerazine (INN)
Drug groups [BR:br08330]
Antibacterial
DG01787 Sulfonamide antibacterial
DG01786 Long-acting sulfonamide
D02435 Sulfamerazine
Antimicrobials [BR:br08307]
Antibacterials
Folic acid biosynthesis inhibitor
Long-acting sulfonamide
D02435 Sulfamerazine (INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 18
1 C8y C 24.3854 -17.0962
2 S4a S 25.6033 -16.3936
3 C8x C 24.3854 -18.5014
4 C8x C 23.2144 -16.3936
5 N1b N 26.8212 -17.0962
6 O3c O 26.5869 -15.4099
7 O3c O 24.6196 -15.4099
8 C8x C 23.2144 -19.2041
9 C8x C 21.9965 -17.0962
10 C8y C 28.0391 -16.3936
11 C8y C 21.9965 -18.5014
12 N5x N 28.0391 -14.9883
13 N5x N 29.2569 -17.0962
14 N1a N 20.7787 -19.2041
15 C8x C 29.2569 -14.2857
16 C8y C 30.4748 -16.3936
17 C8x C 30.4748 -14.9883
18 C1a C 31.6917 -17.0964
BOND 19
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 2
6 2 7 2
7 3 8 1
8 4 9 2
9 5 10 1
10 8 11 2
11 10 12 2
12 10 13 1
13 11 14 1
14 12 15 1
15 13 16 2
16 15 17 2
17 9 11 1
18 16 17 1
19 16 18 1
|
|---|
